Number of employees
40
Annual revenue
$8646000
What We Do: VaxDesign develops in vitro models of human immunity functionally equivalent to the human immune system. We believe our technologies will enable drug and vaccine development companies to obtain better predictions of human outcomes for their therapies than is possible with existing methods. In addition, our MIMIC™ models will provide a rapid and cost-effective solution to our customers. VaxDesign's immunotherapy testing immune system models have the potential to save companies years of development time and millions of dollars of development costs.